Catabasis Pharmaceuticals Top Management
Catabasis Pharmaceuticals employs about 20 people. The company is managed by 22 executives with a total tenure of roughly 186 years, averaging almost 8.0 years of service per executive, having 0.91 employees per reported executive. Analysis of Catabasis Pharmaceuticals' management performance can provide insight into the company performance.
| Jill Milne CEO Co-Founder, CEO and President and Director |
| Michael Ross Chairman Chairman of the Board |
Catabasis |
Catabasis Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of (20.32) % which means that it has lost $20.32 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (210.26) %, meaning that it created substantial loss on money invested by shareholders. Catabasis Pharmaceuticals' management efficiency ratios could be used to measure how well Catabasis Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Catabasis Pharmaceuticals Workforce Comparison
Catabasis Pharmaceuticals is number one stock in number of employees category among related companies. The total workforce of Biotechnology industry is currently estimated at about 30,429. Catabasis Pharmaceuticals adds roughly 20.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.
Catabasis Pharmaceuticals Notable Stakeholders
A Catabasis Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Catabasis Pharmaceuticals often face trade-offs trying to please all of them. Catabasis Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Catabasis Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Michael Jirousek | Co-Founder and Member of Scientific Advisory Board | Profile | |
| Jill Milne | Co-Founder, CEO and President and Director | Profile | |
| Michael Ross | Chairman of the Board | Profile | |
| Angelika Fretzen | Senior Vice President - Product Development | Profile | |
| Deirdre Cunnane | Senior Vice President General Counsel | Profile | |
| Ian Sanderson | CFO, Treasurer | Profile | |
| Deirdre JD | Sr. VP and General Counsel | Profile | |
| Andrew Nichols | Sr. VP of Research | Profile | |
| Ted Hibben | Sr. VP of Corporate Devel. | Profile | |
| Jean George | Director | Profile | |
| Gregg Lapointe | Director | Profile | |
| Michael Kishbauch | Director | Profile | |
| Joanne Beck | Director | Profile | |
| Burt Adelman | Director | Profile | |
| Kenneth Bate | Director | Profile | |
| Hugh Cole | Director | Profile | |
| Nicholas Galakatos | Director | Profile | |
| Ron Laufer | Director | Profile | |
| Rick Modi | Chief Business Officer | Profile | |
| Joanne Donovan | Chief Medical Officer | Profile | |
| Edward Hibben | Chief Business Officer | Profile | |
| Andrea Matthews | IR Contact Officer | Profile |
Catabasis Pharmaceuticals Workforce Analysis
Traditionally, organizations such as Catabasis Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Catabasis Pharmaceuticals within its industry.Catabasis Pharmaceuticals Manpower Efficiency
Return on Catabasis Pharmaceuticals Manpower
| Revenue Per Employee | 12.5K | |
| Revenue Per Executive | 11.4K | |
| Net Loss Per Employee | 11.1M | |
| Net Loss Per Executive | 10.1M | |
| Working Capital Per Employee | 2.8M | |
| Working Capital Per Executive | 2.5M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Consideration for investing in Catabasis Stock
If you are still planning to invest in Catabasis Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Catabasis Pharmaceuticals' history and understand the potential risks before investing.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |